BioSpace News Archive

DoubleRainbow Biosciences (“Double Rainbow”), a sustainable biotech company harnessing bioengineering to improve the quality of human health, announced today a new research collaboration with Kelai Pharmaceuticals (“Kelai”) to explore the potential of biosynthetic kavalactone therapeutics. Kelai will include one of Double Rainbow’s molecules in their ongoing cell transcriptome study.

Remote patient monitoring allows the healthcare professionals to monitor disease and symptom progression remotely and engage with patients virtually to modify the care plans and provide education on self-care, based on changes in the patient’s condition.

According to Vision Research Reports, the global nuclear magnetic resonance spectroscopy market was surpassed at USD 657.3 million in 2021 and is expected to hit around USD 1,025.6 million by 2030, growing at a CAGR of 5.07% from 2022 to 2030

The global cutaneous squamous cell carcinoma treatment market is likely to show upward revenues curve during the forecast period of 2021 to 2031.

Homecare oxygen concentrators are usually used in providing supplemental oxygen to wide range of patients with respiratory problems.

Brain cells with the same “birthdate” are more likely to wire together into cooperative signaling circuits that carry out many functions, including the storage of memories, a new study finds.

City of Hope, one of the largest cancer research and treatment organizations in the United States, is sending the iconic Great Park Balloon in Irvine, California, into the sky with a message of hope for ending the disease that affects 1 in 3 Americans in their lifetime.

Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or “the Company”), a biopharmaceutical company developing transformational vaccines to address significant global health challenges, today announced the appointment of Simon Tarsh, seasoned financial consultant with experience in the life science industry, to its board of directors at BWV’s annual meeting.

KOAG LLC, a Minneapolis-based medical device firm engaged in the design of innovative, topical vascular closure systems, announced today it received FDA clearance for its Vascette® HP device.

PROCEPT® BioRobotics Corporation (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced that members of management will present and host a fireside chat at the upcoming 2022 Wells Fargo healthcare conference.